Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › FP7

SYSMEDIBD · Systems medicine of chronic inflammatory bowel disease

FP7Status: CLOSED1 December 201230 November 2017EU funding €11,999,998

Inflammatory bowel disease (IBD) is a major health problem with severe co-morbidities, requiring life-long treatment. Oscillating processes, like biological clocks are well studied and modeled in a number of systems. Circadian rhythms are extremely important for optimal treatments of patients. Recently, the NfkB pathway has been shown to be oscillating. In this project, we will model NfkB oscillation in chronic inflammatory bowel diseases in animal models and patient cohorts with immunosuppressive treatments and controls. The aim is to build an experimentally validated model the NfkB oscillation in 4D within the gut tissue. Dynamic, experimental validation will be done for various types of cells in the gut by a combination of methods, including single-cell based transcriptomics, multi-photon microscopy and time-dependent, multi-component profiling. The validated model framework will enable searching for critical components of the NfB oscillation and to assess their relevance for the disease in patients. Interfering with the oscillation of biological pathways may provide new possibilities to influence biological processes like inflammation. Hence, we will search (assisted by the models and databases developed) for small molecules interfering with the NfkB oscillation in chemical databases and validate selected candidates in experimental systems. To this end, we will use cell lines with the correct indicator constructs using high content microscopy. To better translate the findings in animal models to patients, we will use a mouse model with transplanted human tissue so that we can verify the mathematical model in human tissue and verify functionality of small molecules in vivo.Owing to its systems, highly focused approach, the project will generate substantial insights into key mechanisms underlying IBD and will provide ways to modulate the oscillatory behavior of the NfB in IBD and IBD-dependent co-morbidities.

Consortium · 13 organisations

coordinator

THE UNIVERSITY OF MANCHESTER

UK · €3,262,748

participant

LIFEGLIMMER GMBH

DE · €600,000

participant

UNIVERSITAETSKLINIKUM AACHEN

DE · €994,800

participant

DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG

DE · €849,997

participant

CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL

DE · €1,493,400

participant

UNIVERSITEIT MAASTRICHT

NL · €1,095,434

participant

THE UNIVERSITY OF AUCKLAND

NZ · €18,000

participant

GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG

DE · €219,940

participant

ARTTIC

FR · €181,060

participant

GENEXPLAIN GMBH

DE · €499,960

participant

THE UNIVERSITY OF LIVERPOOL

UK · €992,250

participant

UNIVERSITY OF WARWICK

UK · €942,410

participant

THE HEBREW UNIVERSITY OF JERUSALEM

IL · €849,999

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.